Jacobs Levy Equity Management’s VivoSim Labs VIVS Stock Holding History

Jacobs Levy Equity Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-46	Closed	-$11K	–	1045
2019 Q1	$11K	Sell	46 -101	-69%	-$25.4K	﹤0.01%	949
2018 Q4	$34K	Buy	+147	New	+$37K	﹤0.01%	958

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jacobs Levy Equity Management's VIVS Position: Q2 2019 in Review

Jacobs Levy Equity Management sold out of VivoSim Labs (VIVS) in Q2 2019, closing a stake of 46 shares — an estimated $11K sold.

Jacobs Levy Equity Management first reported a position in VIVS in Q4 2018 and held it in 2 quarters. The position peaked at $34K in Q4 2018. 93 funds tracked by Wall St. Rank hold VIVS as of Q2 2019.

Jacobs Levy Equity Management reported no remaining VivoSim Labs position as of Q2 2019 after selling out during the quarter.
Jacobs Levy Equity Management sold 46 VivoSim Labs shares in Q2 2019, an estimated $11K.
Jacobs Levy Equity Management first reported a position in VivoSim Labs in Q4 2018 and held it in 2 quarters.
Jacobs Levy Equity Management's VivoSim Labs position peaked at $34K in Q4 2018.
93 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.